These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8103353)

  • 1. Tropisetron and the 5-HT3 Antiemetics in Perspective. Proceedings of an international symposium. Vienna, Austria, October 2, 1992.
    Ann Oncol; 1993; 4 Suppl 3():1-47. PubMed ID: 8103353
    [No Abstract]   [Full Text] [Related]  

  • 2. Tropisetron (Navoban): just another "setron"?
    Aapro MS
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):1-2. PubMed ID: 9113118
    [No Abstract]   [Full Text] [Related]  

  • 3. Current issues in the management of nausea and vomiting.
    Gralla RJ
    Ann Oncol; 1993; 4 Suppl 3():3-7. PubMed ID: 8363996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
    Gershanovich M; Kolygin B; Pirgach N
    Ann Oncol; 1993; 4 Suppl 3():35-7. PubMed ID: 8363998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Always more "setrons": how many do we need?
    Aapro MS
    Support Care Cancer; 1997 Jan; 5(1):1-2. PubMed ID: 9010981
    [No Abstract]   [Full Text] [Related]  

  • 6. Navoban (tropisetron) and 5HT3 antiemetics in perspective. Hotel Inter-Continental, Vienna, Austria, 2 October 1992.
    Anticancer Drugs; 1992 Dec; 3(6):695. PubMed ID: 1288740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with the clinical use of navoban].
    Voznyĭ EK; Dobrovol'skaia NI; Volkova LA
    Vopr Onkol; 1995; 41(1):70-1. PubMed ID: 7667947
    [No Abstract]   [Full Text] [Related]  

  • 8. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy.
    Bruntsch U; Rüfenacht E; Parker I; Drechsler S; de Bruijn K
    Ann Oncol; 1993; 4 Suppl 3():25-9. PubMed ID: 8363995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Navoban--the new 5HT3-antagonist].
    Internist (Berl); 1994 May; 35(5 Suppl):1-8. PubMed ID: 9209536
    [No Abstract]   [Full Text] [Related]  

  • 10. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
    Simpson K; Spencer CM; McClellan KJ
    Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of tropisetron in its clinical perspective.
    de Bruijn KM
    Ann Oncol; 1993; 4 Suppl 3():19-23. PubMed ID: 8363994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compassionate use of tropisetron in patients at high risk of severe emesis.
    Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M
    Ann Oncol; 1993; 4 Suppl 3():43-5. PubMed ID: 8364000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tropisetron (Navoban) in controlling emesis induced in children by anti-cancer therapy.
    Rosso P; Cordero di Montezemolo L; Vivenza C; Nasi C; Tonello M; Valle P; Madon E
    Tumori; 1994 Dec; 80(6):459-63. PubMed ID: 7900236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience.
    Sorbe B
    Ann Oncol; 1993; 4 Suppl 3():39-42. PubMed ID: 8363999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced nausea and vomiting.
    Hesketh PJ
    N Engl J Med; 2008 Jun; 358(23):2482-94. PubMed ID: 18525044
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms and management of nausea and emesis.
    Dicato M
    Oncology; 1996 Jun; 53 Suppl 1():1-3. PubMed ID: 8692544
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.